ESC 365 - SGLT2 inhibitors should be given to all patients with heart failure - CON.

ESC Premium Access

SGLT2 inhibitors should be given to all patients with heart failure - CON.

Session: Controversies in Heart Failure: SGLT2 Inhibitors Should Be Given to All Patients

Topic: Chronic Heart Failure

Speaker: Professor R. De Boer (Rotterdam, NL)

Event: ESC Congress 2020

Congress Presentation

About the speaker

Professor Rudolf De Boer

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

50 presentations

1 follower

2 more presentations in this session

SGLT2 inhibitors should be given to all patients with heart failure - PRO.

Speaker: Professor J. McMurray (Glasgow, GB)

SGLT2 inhibitors should be given to all patients with heart failure - Discussion.

Access the full session

Controversies in Heart Failure: SGLT2 Inhibitors Should Be Given to All Patients

Speakers: Professor R. De Boer, Professor J. McMurray

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

Related content

ESC Premium Access

Acute myocardial infarction with cardiogenic shock: case presentation.

29 August 2021

ESC Premium Access

Triglycerides: the underestimated player.

27 August 2021

ESC Premium Access

Inflammatory targets in atherosclerosis.

27 August 2021

ESC 365 is supported by